Bill > HR6220

This bill directs the Secretary of Health and Human Services (HHS) to conduct a comprehensive study on neonatal abstinence syndrome (NAS), a condition affecting newborns who experience withdrawal symptoms after exposure to drugs in the womb. The study will focus on understanding the prevalence of NAS and examining infant and maternal health outcomes related to pediatric transitional care facilities, which are residential centers providing treatment for infants experiencing drug withdrawal. Specifically, the Secretary must identify challenges in collecting accurate data about NAS among Medicaid beneficiaries and assess the range of services and support available to these patients. Within three years of the bill's enactment, the Secretary is required to submit a detailed report to Congress containing study findings and potential recommendations, which must also be published on a public website. The bill defines a pediatric transitional care facility as a residential center offering inpatient or outpatient treatment for infants with NAS and considers a "State" to include all U.S. states, the District of Columbia, and U.S. territories. The study aims to provide critical insights into addressing the complex healthcare needs of infants affected by prenatal drug exposure.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/6220/all-info